Acanthopanax senticosus endophytic bacterium HASX4 for producing kaempferol and isofraxidin and application
The microbial fermentation method uses the endophytic bacteria HASX4 to produce kaempferol and isazinidine, which solves the problem that the extraction of the secondary metabolites of kaempferol is not conducive to industrial production, and achieves the sustainable utilization of resources and guarantees quality.
Patent Information
- Application Number
- CN202411064923.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-05
- Publication Date
- 2024-11-15
- Estimated Expiration
- 2044-08-05
AI Technical Summary
Extracting the secondary metabolites of prickly 500 is not conducive to industrial production, resulting in resource shortage and difficulty in ensuring quality.
It provides a plant of kaempferol and isazinazin saphenyl endophytic bacteria HASX4, which produces these secondary metabolites through microbial fermentation, and uses their good antioxidant and biological activities to achieve industrial-scale production.
Through microbial fermentation, the important secondary metabolites of kaempferol and isazinidine are successfully extracted, which meets the needs of industrial production, is efficient, simple and suitable for large-scale production, ensuring the sustainable utilization and quality of resources stability.
Smart Images

Figure CN118956664A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the field of microorganisms, and in particular to an endophytic bacterium HASX4 of Acanthopanax senticosus producing kaempferol and isoflavone and an application thereof. Background Art
[0002] Acanthopanax senticosus is the dried root, rhizome or stem of Acanthopanax seuticosus (Rupr.et Maxim.) Harms of the Araliaceae family. It is one of the key varieties of cold-earth dragon medicine, and has the effects of invigorating qi and strengthening spleen, nourishing kidney and calming nerves. Acanthopanax senticosus is rich in glycosides, flavonoids, polysaccharides, trace elements and amino acids and other active chemical components, and has anti-fatigue, anti-inflammatory, anti-tumor, anti-hypertensive, liver-protecting, and hypoglycemic effects. At the same time, it can also regulate body dysfunction, improve cardiovascular and cerebrovascular microcirculation, improve myocardial ischemia, and enhance body immune function. It is now widely used in the pharmaceutical and food industries.
[0003] Acanthopanax senticosus is mainly produced in Heilongjiang. The cold-region black soil creates the unique quality of Acanthopanax senticosus. It has now become the leading variety of cold-region dragon medicine and is well-known both at home and abroad. Due to the rising demand for Acanthopanax senticosus, the gradual reduction of forest area and blind excavation, Acanthopanax senticosus resources are facing challenges. At present, Acanthopanax senticosus is a national second-level endangered species and a third-level key protected variety.
[0004] In view of the endangered status and quality advantages of Acanthopanax senticosus, various aspects of research on Acanthopanax senticosus have become a hot topic. The separation and extraction of Acanthopanax senticosus secondary metabolites from Acanthopanax senticosus plant tissues requires a large amount of Acanthopanax senticosus raw materials, which is not conducive to industrial production. Summary of the invention
[0005] The invention aims to solve the problem that the existing method for extracting secondary metabolites of Acanthopanax senticosus is not conducive to industrial production, and provides an Acanthopanax senticosus endophytic bacterium HASX4 producing kaempferol and isofrazinidine and its application.
[0006] The present invention provides an endophytic bacterium HASX4 of Acanthopanax senticosus producing kaempferol and isoflurane, which is Pantoea agglomerans HASX4, which has been deposited in China Center for Type Culture Collection, the deposit address is Wuhan University, Wuhan, China, the deposit date is May 16, 2024, and the deposit number is CCTCC NO: M 2024971.
[0007] The colony of the Acanthopanax senticosus endophytic bacteria HASX4 of the present invention is light yellow and moist in texture, and the bacterial body is rod-shaped and has flagella.
[0008] The Acanthopanax senticosus endophytic bacterium HASX4 of the present invention is a facultative anaerobic bacterium, is Gram-negative in gram staining, is positive in starch hydrolysis test, is positive in gelatin liquefaction test, is positive in catalase test, is positive in biofilm formation, is positive in VP test, has an optimum pH of 6, an optimum growth temperature of 37°C and an optimum salt tolerance of 4%.
[0009] The endophytic bacteria HASX4 of Acanthopanax senticosus of the present invention has a similarity of 100% with Pantoea agglomerans (CP034469.1) through 16S rDNA sequence comparison analysis. The endophytic bacteria HASX4 of Acanthopanax senticosus of the present invention is Pantoea agglomerans, as determined by combining bacterial morphological characteristics, growth conditions, and physiological and biochemical identification results.
[0010] The present invention also provides application of Acanthopanax senticosus endophytic bacteria HASX4 in fermentation to produce kaempferol and isoflurane.
[0011] The invention also provides application of endophytic bacteria HASX4 of Acanthopanax senticosus in in vitro anti-oxidation.
[0012] Beneficial effects of the present invention:
[0013] The present invention separates an endogenous bacterium HASX4 from Acanthopanax senticosus, which is identified as Pantoea agglomerans. The strain has good antioxidant activity. After secondary metabolite analysis of its fermentation broth, it is found that the strain can produce kaempferol and isofraquinone. Kaempferol is a flavonoid compound, which has the nutritional and health-care effects of anti-oxidation, anti-inflammatory, anti-cancer, prevention and treatment of diabetes, atherosclerosis and osteoporosis, protection of nerves, liver and myocardium, inhibition of protein kinase, etc. Isofraquinone is a hydroxycoumarin monomer substance and is one of the indicator components of Acanthopanax senticosus. Isofraquinone has the effects of anti-liver cancer, inhibiting the proliferation of human colorectal cancer cells, and treating neurodegenerative diseases, and protects lipid metabolism disorders and non-alcoholic fatty liver induced by a high-fat diet.
[0014] The invention can produce Acanthopanax senticosus secondary metabolites through microbial fermentation, and is suitable for industrial production due to rapid microbial reproduction and simple product extraction, and can provide a new method for producing isofraquinone and kaempferol, the effective ingredients in Acanthopanax senticosus, by using microbial fermentation. BRIEF DESCRIPTION OF THE DRAWINGS
[0015] Figure 1 This is a colony photo of the endophytic bacteria HASX4 of Acanthopanax senticosus;
[0016] Figure 2 This is a photo of the bacterial body of HASX4, an endophytic bacterium of Acanthopanax senticosus.
[0017] Figure 3is the phylogenetic tree of the endophytic bacteria HASX4 of Acanthopanax senticosus;
[0018] Figure 4 The scavenging ability of the fermentation liquid of Acanthopanax senticosus endophytic bacteria HASX4 on DPPH free radicals;
[0019] Figure 5 The scavenging ability of the fermentation liquid of Acanthopanax senticosus endophytic bacteria HASX4 on ·OH free radicals;
[0020] Figure 6 The results of HPLC analysis of isofraxidin in the fermentation broth of Acanthopanax senticosus endophytic bacteria HASX4;
[0021] Figure 7 The results of HPLC analysis of kaempferol in the fermentation broth of endophytic bacteria HASX4 from Acanthopanax senticosus.
[0022] Figure 8 For crystal A 1 H NMR spectroscopy;
[0023] Fig. 9 For crystal B 1 H NMR spectrum. DETAILED DESCRIPTION
[0024] The embodiments of the present invention are described in detail below. The following embodiments are implemented on the premise of the technical solution of the present invention, and detailed implementation schemes and specific operation processes are given, but the protection scope of the present invention is not limited to the following embodiments.
[0025] Embodiment 1:
[0026] The Acanthopanax endophytic bacteria HASX4 of this embodiment is Pantoea agglomerans HASX4, which has been deposited in the China Center for Type Culture Collection, the deposit address is Wuhan University, Wuhan, China, the deposit date is May 16, 2024, and the deposit number is CCTCC NO: M 2024971.
[0027] The method for obtaining the endophytic bacteria HASX4 of Acanthopanax senticosus in this embodiment is as follows:
[0028] Take the leaves of Acanthopanax seuticosus (Rupr. et Maxim.) Harms (this Acanthopanax was collected from Mishan City, Heilongjiang Province) of the Araliaceae family, and disinfect their surfaces. The disinfection procedure is as follows: soak the leaves in 75% alcohol for 30 seconds, then wash with sterile water, rinse in sodium hypochlorite for 6-8 minutes, wash with sterile water, then soak in 75% alcohol for 30 seconds, and finally wash three times with sterile water.
[0029] Use a sterile scalpel to cut the disinfected leaves into 1 cm2 Thin slices were made and the cut surface was embedded in NA medium and cultured at 37℃ for 1-3 days. The sterile water wash solution of the last sterilization procedure was removed and inoculated in NA medium. The uncut experimental materials after sterilization were placed on NA medium, rolled once, and then taken out and cultured together with the endophytic bacteria isolation medium as a control.
[0030] Preparation of NA culture medium: Add 6g beef extract, 20g peptone, 10g NaCl and 20g agar powder to boiling water in sequence. After the agar powder is completely dissolved, add water to make up to 1L, adjust the pH to 7.0-7.2, divide into portions, and place in an autoclave at 121°C for 30 minutes. After cooling to room temperature, keep it for later use.
[0031] The endophytic bacteria HASX4 was isolated from Acanthopanax senticosus leaves. No bacteria grew in the negative control plate and negative control liquid culture medium, and this was repeated many times, thus proving that the isolated bacteria were endophytic bacteria of Acanthopanax senticosus.
[0032] Example 2: Identification of endophytic bacteria HASX4 from Acanthopanax senticosus
[0033] 1. Morphological characteristics of endophytic bacteria HASX4 from Acanthopanax senticosus
[0034] The colony of HASX4, an endophytic bacterium of Acanthopanax senticosus, is light yellow and moist. The bacteria are rod-shaped and have flagella. Figure 1 As shown, the bacteria photos are as follows Figure 2 shown.
[0035] 2. Physiological and biochemical characteristics of endophytic bacteria HASX4 in Acanthopanax senticosus
[0036] The endophytic bacterium HASX4 of Acanthopanax senticosus is a facultative anaerobic bacterium, which is negative in Gram staining, positive in starch hydrolysis test, positive in gelatin liquefaction test, positive in catalase test, positive in biofilm formation, positive in VP test, with an optimum pH of 6, an optimum growth temperature of 37℃, and an optimum salinity tolerance of 4%.
[0037] 3. Molecular identification of endophytic bacteria HASX4 in Acanthopanax senticosus
[0038] PCR amplification was performed using universal primers 27F (5'-AGAGTTTGATCCTGGCTCAG-3') and 1492R (5'-TACGGTTACCTTGTTACGACTT-3') for bacterial 16S rDNA gene. The product was tested by 1.0% agarose gel electrophoresis, and an amplified fragment was obtained at 1406 bp. Shanghai Shenggong Biotechnology Co., Ltd. was commissioned to sequence the strain HASX4. The 16S rDNA sequence of the endophytic bacterium HASX4 of Acanthopanax senticosus is shown in SEQ ID NO: 1 in the sequence table. The sequencing results were submitted to the NCBI database, analyzed and aligned using BLAST, and then the phylogenetic tree of the endophytic bacterium HASX4 was constructed using MEGA 7 software. The construction results of the phylogenetic tree of the endophytic bacterium HASX4 of Acanthopanax senticosus are shown in Figure 3 The similarity between HASX4 and Pantoea agglomerans (CP034469.1) reached 100%. Based on the morphological characteristics, growth conditions, and physiological and biochemical identification results, it was determined that HASX4 was Pantoea agglomerans.
[0039] Example 3: Analysis of the Antioxidant Activity of Acanthopanax Senticosus Endophytic Bacteria HASX4
[0040] Activation of endogenous bacteria HASX4: Take endogenous bacteria HASX4, inoculate it on the surface of NA culture medium under sterile conditions, and culture it at 37°C for 1 day for later use.
[0041] Preparation of fermentation broth of endophytic bacteria HASX4: Take the activated endophytic bacteria HASX4, pick the hyphae under sterile conditions and inoculate them into 50 mL NB medium, and culture them in a shaking incubator at 37°C and 120 r / min for 3 days to make 1×10 7 CFU / mL seed liquid; the seed liquid was transferred to 3L sterilized NB medium at an inoculation rate of 20% (v / v), and cultured in a shaking incubator at 37°C and 120r / min for 7 days, the fermentation liquid was collected, concentrated under reduced pressure, extracted with ethyl acetate (3×100mL), and concentrated at low temperature to an extract, dried, and the fermentation liquid powder of the endophytic bacteria HASX4 was obtained for later use.
[0042] 1. Determination of DPPH free radical scavenging ability
[0043] Accurately weigh 5.9 mg of DPPH, add a certain amount of methanol to dissolve it, and then dilute it to 100 mL. Oscillate evenly to prepare a solution with a mass concentration of 0.15 mmol·L -1 DPPH solution; accurately weigh 2 mg of Vc, add a certain amount of methanol to dissolve it and then dilute it to 20 mL to obtain 100 μg mL -1 of reference solution;
[0044] The fermentation broth powder of the Acanthopanax senticosus endophytic bacteria HASX4 was dissolved in an appropriate amount of methanol to prepare a concentration of 200 μg mL -1 of the test sample solution.
[0045] Dilute the above-mentioned reference and test solutions in sequence, and dilute each solution to a concentration gradient of 100 μg mL -1 , 50μg·mL -1 , 25 μg·mL -1 , 12.5 μg·mL -1 , 6.25 μg·mL -1 2 mL of each solution was pipetted into a test tube, and methanol was used as a blank control group. 0.15 mmol·L -1 4 mL of DPPH solution was placed in the dark for 30 min, and the absorbance of each sample was measured at 517 nm (n = 3). The DPPH free radical scavenging rate was calculated as follows:
[0046]
[0047] In the formula, A i Indicates the absorbance value when the test product and DPPH solution are added simultaneously; A j A0 represents the absorbance value when the test sample and blank control are added at the same time; A1 represents the absorbance value when the blank control and DPPH solution are added at the same time.
[0048] The scavenging ability of HASX4 fermentation broth of Acanthopanax senticosus on DPPH free radicals Figure 4 shown.
[0049] 2. Determination of OH radical scavenging ability
[0050] Pipette 2 mL of each test solution of different concentrations into a test tube, and add 2 mL of 6 mmol·L -1 FeSO4, 2mL 6mmol·L -1 of H2O2, shake and mix, let stand for 10 min, then add 2mL 6mmol·L -1 The salicylic acid-ethanol solution was placed at 37°C for 30 min, and the absorbance of each sample was measured at 510 nm (n=3). The OH radical scavenging rate was calculated as follows:
[0051]
[0052] In the formula, A1 represents the absorbance value of the added sample; A2 represents the absorbance value when distilled water replaces H2O2 to eliminate the influence of the sample's own color; A0 represents the absorbance value when anhydrous ethanol replaces the sample as a blank control.
[0053] The scavenging ability of ·OH free radicals in the fermentation broth of Acanthopanax senticosus endophytic bacteria HASX4 Figure 5 shown.
[0054] from Figure 4 and Figure 5 It can be seen that the scavenging rate of DPPH free radical and ·OH free radical is related to the concentration of the fermentation liquid, and the concentration of the fermentation liquid of the endophytic bacteria HASX4 of Acanthopanax senticosus is positively correlated with the antioxidant capacity. The experimental results show that the fermentation liquid of the endophytic bacteria HASX4 of Acanthopanax senticosus has good antioxidant activity.
[0055] When the fermentation broth concentration of Acanthopanax senticosus endophytic bacteria HASX4 was 100 μg mL -1 When the scavenging rate of DPPH free radical was 64.26%, the half scavenging rate (IC 50 value) reached 41.708 μg·mL -1 The scavenging rate of OH free radicals reached 67.95%, and the half scavenging rate (IC 50 value) reached 55.28 μg·mL -1 .
[0056] Example 4: HPLC analysis of fermentation broth of Acanthopanax senticosus endophytic bacteria HASX4
[0057] Activation of endogenous bacteria HASX4: Take endogenous bacteria HASX4, inoculate it on the surface of NA culture medium under sterile conditions, and culture it at 37°C for 1 day for later use.
[0058] Preparation of fermentation broth of endophytic bacteria HASX4: Take the activated endophytic bacteria HASX4, pick the hyphae under sterile conditions and inoculate them into 50 mL NB medium, and culture them in a shaking incubator at 37°C and 120 r / min for 3 days to make 1×10 7 CFU / mL of seed liquid; the seed liquid was transferred to 3L sterilized NB medium at a 20% (v / v) inoculation amount, cultured at 37°C, 120r / min shaking for 7 days, and the fermentation liquid was collected for later use.
[0059] 1. Preparation of test solution
[0060] Take 300 mL of the fermentation broth of endophytic bacteria HASX4, concentrate it under reduced pressure at 50 °C, extract the concentrated fermentation broth with ethyl acetate three times (3×100 mL), combine the extracts, concentrate to dryness at 50 °C, dissolve it with 1 mL of methanol, and use it as the test solution for later use.
[0061] 2. Preparation of reference solution
[0062] Accurately weigh 1 mg each of isoflurane and kaempferol reference substances, place them in a 1 mL centrifuge tube, add 1 mL of chromatographic methanol to dissolve, and prepare reference substance solutions for later use.
[0063] 10 g of Acanthopanax senticosus leaf powder was dissolved in 100 mL of ethyl acetate solution, extracted by ultrasonic wave for 1 hour, filtered, and the solution was concentrated to 10 mL of Acanthopanax senticosus solution under low temperature environment, which was used as a reference substance.
[0064] Take 300 mL of NB culture medium and concentrate it under reduced pressure at 50°C. Extract the concentrated NB culture medium with ethyl acetate three times (3×100 mL). Combine the extracts, concentrate to dryness at 50°C, dissolve them in 1 mL of methanol and use them as blank control solution for later use.
[0065] 3. HPLC conditions
[0066] Chromatographic column: Venusil XBP-C 18 Column (4.6 mm × 250 mm, 5 μm, USA) flow 1: methanol: water (45:55) 0.2% phosphoric acid; flow rate: 1 mL·min -1 ; Column temperature: 25°C; Detection wavelength: 254 nm; Injection volume: 10 μL. Flow 2: methanol: water (60:40) 0.2% phosphoric acid; Flow rate: 1 mL·min -1 ; Column temperature: 25℃; Detection wavelength: 290nm; Injection volume: 10μL.
[0067] The fermentation broth of endophytic bacteria HASX4 was analyzed by HPLC. Figure 6 , 7 shown. Figure 6 A is HASX4 fermentation broth, B is isoflurane, C is Acanthopanax senticosus leaf crude drug, and D is NB blank control. Figure 6 It can be seen that the fermentation broth of the endophytic bacteria HASX4 of Acanthopanax senticosus has the same chromatographic peak as the isoflurane reference substance at the same retention time, and the blank control (NB) has no interference, indicating that the fermentation broth of the bacteria may contain isoflurane. Figure 7 A is HASX4 fermentation liquid, B is kaempferol, C is Acanthopanax senticosus leaf crude drug, and D is NB blank control. Figure 7 It can be seen that the fermentation broth of the endophytic bacteria HASX4 of Acanthopanax senticosus has the same chromatographic peak as the kaempferol reference substance at the same retention time, and the blank control (NB) has no interference, indicating that the fermentation broth of the bacteria may contain kaempferol.
[0068] Example 5: Separation of isoflurane and kaempferol from the fermentation broth of endophytic bacteria HASX4 of Acanthopanax senticosus
[0069] According to the HPLC analysis results of the fermentation broth of endophytic bacteria HASX4 from Acanthopanax senticosus, a separation process was designed for isofraquinone and kaempferol contained therein.
[0070] Take 10L of the fermentation liquid of endophytic bacteria HASX4 and slowly pass it through D 101 The macroporous resin column was eluted with 30%, 50%, 70% and 90% ethanol in a gradient manner, and the eluents were collected and the solvent was recovered to obtain D 101 Each elution part of the macroporous resin column.
[0071] Take 30% D 101 The elution part of the macroporous resin column was separated by a polyamide column chromatography, and gradient elution was performed using 30%, 50%, 70% and 90% ethanol. The eluate was collected (10 mL / bottle), and the components 150 to 208 in the 70% ethanol eluate were combined to obtain a crude product A.
[0072] The crude product A was separated by silica gel column using petroleum ether-ethyl acetate (1:1) as eluent, the eluent was collected (10 mL / bottle), components 120 to 180 were combined, and recrystallized multiple times to obtain crystal A.
[0073] Crystal A: Yellow crystalline powder, needle-like, easily soluble in methanol, ethanol, chloroform, soluble in organic solvents such as ether. Crystal A 1 H-NMR (400 MHz, MeOD) δ: 8.1-8.05 (m, 6H), 6.94-6.87 (m, 6H), 6.40 (d, J = 2.1 Hz, 3H), 6.19 (d, J = 2.1 Hz, 3H). Figure 8 shown.
[0074] According to HPLC and 1 H-NMR and comparison with the data in the literature, the physical and chemical properties of crystal A and 1 The H-NMR result was completely consistent with kaempferol, therefore, crystal A was kaempferol.
[0075] Take 5L of the fermentation liquid of endophytic bacteria HASX4, concentrate it under reduced pressure at 50℃ to 200mL, extract it with ether 3 times (3×100mL), and combine the extracts. Concentrate the extract to dryness under reduced pressure at 50℃ to obtain the ether extraction part. Separate the ether extraction part through a silica gel column, elute with petroleum ether-ethyl acetate (5:1) and petroleum ether-ethyl acetate (1:1), combine the 46-92 components of the petroleum ether-ethyl acetate (1:1) eluate, and recrystallize it with ethanol to obtain crystal B.
[0076] Crystal B: light yellow, easily soluble in methanol, ethanol, acetone, chloroform, and soluble in ether. 1H-NMR (400MHz, MeOD) δ: 7.76 (d, J = 9.5Hz, 1H), 6.13 (d, J = 9.4Hz, 1H, vinyl proton), 6.83 (s, 1H, C5-H), 3.85 (s, 3H, C6-OH3), 3.81 (s, 3H, C8-OH3). The results are shown in Fig. 9 .
[0077] According to HPLC and 1 H-NMR and comparison with the data in the literature, the physical and chemical properties of crystal B and 1 The H-NMR result was completely consistent with that of isofraquinone, and therefore, Crystal B was identified as isofraquinone.
Claims
1. An endophytic bacterium of Acanthopanax senticosus HASX4 producing kaempferol and isoflurane, characterized in that: The endophytic bacterium HASX4 of Acanthopanax senticosus is Pantoea agglomerans HASX4, which has been deposited in the China Center for Type Culture Collection, the deposit address is Wuhan University, Wuhan, China, the deposit date is May 16, 2024, and the deposit number is CCTCC NO: M 2024971.
2. Use of the Acanthopanax senticosus endophytic bacteria HASX4 as claimed in claim 1 in fermentation to produce kaempferol and isoflurane.
3. Use of the endophytic bacteria HASX4 of Acanthopanax senticosus as claimed in claim 1 in in vitro anti-oxidation.
Citation Information
Patent Citations
Eleutherococcous senticosus endosymbiotic bacteria capable of producing coffeic acid
CN102154185A
Endophytic fungi capable of improving content of isofraxidin in Radix Acanthopanacis Semticosi through fermenting Radix Acanthopanacis Semticosi
CN102676404A
Method for multi-omics analysis of community comprehensive response of anti-susceptible konjak to Pcc infection
CN117683865A
Pantoea agglomerans SH1 and its use
KR1020160057920A
Endophytic fungus of ginkgo biloba and metabolite product and application thereof
WO2019119992A1
Cited By
Method for producing eleutheroside E and oleanolic acid through microbial fermentation
CN120989191A
A method for producing eleutheroside E and oleanolic acid by microbial fermentation
CN120989191B
